3-BROMO-2-CHLORO-4-(TRIFLUOROMETHYL)PYRIDINE, 95.0%, 250mg

1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborlan-2-yl-)-1H-pyrazole, 98.0%, 25g

N-Acetyl-2-piperidone, 97.0%, 25g

3-Bromo-2-methoxy-6-methylpyridine, 95.0%, 5g

4,4'-(Propane-1,3-diylbis(oxy))bis(benzene-1,3-diamine) tetrahydrochloride, 95.0%, 5g

Colonna capillare per GC ROTI®Cap-5, 25 m, 0.32 mm, 3.00 µm, 1 Pezzo(i)

4-Bromo-2,6-difluorophenylboronic acid, 95.0%, 25g

methyl 2-(6-chloropyrimidin-4-yl)acetate, 95.0%, 250mg

4-Aminophenyl 4-aminobenzoate, 95.0%, 250mg

(1S,2S)-2-(benzyloxy)cyclopentan-1-amine (hydrochloride), 1g

2,3-Dimethyl-1 H -indole-5-carboxylic acid ethyl ester, 95.0%, 100mg

(S)-1-((1S,3aR,4S,7aR)-4-((tert-Butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)ethan-1-ol, 98%, 100mg

3,5-Dineopentyl-4,5,7a,8,9,10,11,11a,12,13,14,15-dodecahydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine 4-oxide, 98%, 100mg